Effect of dutasteride on androgen-response gene expression during the tumor regrowth phase of intermittent androgen ablation therapy in patients with advanced prostate cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Aug 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Feb 2013 Results presented at the 2013 Genitourinary Cancers Symposium.
24 Jan 2013 New source identified and integrated (Robert H. Lurie Comprehensive Cancer Center record: NU-E08U1).
24 Jun 2011 Planned end date changed from 1 Mar 2012 to 1 Mar 2014 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com